Fund shareholders of Brii Biosciences Ltd
ISIN KYG1645A1094 · China · LEI 5493000GCQ47MM4EKK44
- Fund shareholders
- 6
- Of which ETFs
- 4 2 other funds
- Value held
- 299.7K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 697,000 | 139K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 543,000 | 94.2K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 186,500 | 32.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 133,500 | 23.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust | 50,500 | 10.1K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 3,000 | 598.4 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | 0 | 1,613,500 | -2.3 % |
| 2026Q1 | 6 | 0 | 1,652,000 | +1.0 % |
| 2025Q4 | 6 | +2 | 1,635,500 | +74.5 % |
| 2025Q3 | 4 | 0 | 937,000 | +148.9 % |
| 2025Q2 | 4 | 0 | 376,500 | 0.0 % |
| 2025Q1 | 4 | -1 | 376,500 | -14.5 % |
| 2024Q4 | 5 | -2 | 440,500 | -56.3 % |
| 2024Q3 | 7 | +2 | 1,009,000 | +75.6 % |
| 2024Q2 | 5 | -2 | 574,500 | -91.5 % |
| 2024Q1 | 7 | -2 | 6,752,500 | -6.7 % |
| 2023Q4 | 9 | 7,237,500 |
Cite this page
Titelia. "Fund shareholders of Brii Biosciences Ltd". https://titelia.com/en/stocks/brii-biosciences-ltd-KYG1645A1094